>>> US Research Calls

Research Calls

  • Upgrades:
    • 1Life Healthcare (ONEM) upgraded to Buy from Neutral at BTIG Research; tgt $15
    • Adverum Biotech (ADVM) upgraded to Buy from Hold at Truist; tgt $4
    • Allegiance Bancshares (ABTX) upgraded to Outperform from Mkt Perform at Raymond James; tgt $43
    • Carter Bank & Trust (CARE) upgraded to Outperform from Mkt Perform at Raymond James; tgt $16
    • Cerence (CRNC) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt lowered to $27
    • Endeavor Group (EDR) upgraded to Buy from Neutral at Citigroup; tgt $25
    • EPR Properties (EPR) upgraded to Buy from Neutral at Janney
    • First Mid-Illinois Bancshares (FMBH) upgraded to Outperform from Mkt Perform at Raymond James; tgt $45
    • Lamar Advertising (LAMR) upgraded to Buy from Neutral at Citigroup; tgt lowered to $108
    • Pinnacle Finl (PNFP) upgraded to Outperform from Mkt Perform at Raymond James; tgt $85
    • PPL Corp (PPL) upgraded to Outperform from In-line at Evercore ISI; tgt $30
    • Regions Fincl (RF) upgraded to Outperform from Mkt Perform at Raymond James; tgt $23
    • Skyline Champion (SKY) upgraded to Outperform from Neutral at Wedbush; tgt $70
    • Tenaris (TS) upgraded to Buy from Hold at Jefferies; tgt raised to $46
    • Whitestone REIT (WSR) upgraded to Mkt Outperform from Mkt Perform at JMP Securities; tgt $13
  • Downgrades:
    • Aspen Tech (AZPN) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $162
    • Blend Labs (BLND) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Boston Beer Co (SAM) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $331
    • Cambridge Bancorp (CATC) downgraded to Mkt Perform from Outperform at Raymond James
    • CapStar Financial (CSTR) downgraded to Mkt Perform from Outperform at Raymond James
    • Consolidated Comms (CNSL) downgraded to Sell from Neutral at Citigroup; tgt $5
    • First Commonwealth (FCF) downgraded to Mkt Perform from Outperform at Raymond James
    • Freeport-McMoRan (FCX) downgraded to Peer Perform from Outperform at Wolfe Research
    • Guaranty Bancshares (GNTY) downgraded to Mkt Perform from Outperform at Raymond James
    • Hilltop Holdings (HTH) downgraded to Underperform from Mkt Perform at Raymond James
    • Kellogg (K) downgraded to Neutral from Buy at UBS; tgt lowered to $74
    • Kohl's (KSS) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $26
    • Live Oak Bancshares (LOB) downgraded to Mkt Perform from Outperform at Raymond James
    • Otis Worldwide (OTIS) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $62
    • PNC (PNC) downgraded to Mkt Perform from Outperform at Raymond James
    • Rio Tinto (RIO) downgraded to Sell from Hold at Berenberg
    • Sealed Air (SEE) downgraded to Neutral from Buy at BofA Securities; tgt $67
    • Southern Copper (SCCO) downgraded to Underperform from Peer Perform at Wolfe Research
    • Veritex Holdings (VBTX) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $38
    • VTEX (VTEX) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
  • Others:
    • Alector (ALEC) initiated with a Buy at Mizuho; tgt $15
    • Athira Pharma (ATHA) initiated with a Buy at Mizuho; tgt $6
    • BioXcel Therapeutics (BTAI) initiated with a Buy at Mizuho; tgt $19
    • Cerevel Therapeutics (CERE) initiated with a Neutral at Mizuho; tgt $30
    • CTI BioPharma (CTIC) initiated with an Outperform at Cowen; tgt $10
    • Datadog (DDOG) initiated with a Hold at Canaccord Genuity; tgt $120
    • Duolingo (DUOL) initiated with a Buy at Needham; tgt $115
    • Elastic (ESTC) initiated with a Buy at Canaccord Genuity; tgt $100
    • EVgo Inc. (EVGO) initiated with a Hold at Jefferies; tgt $5.50
    • EyePoint Pharmaceuticals (EYPT) initiated with a Buy at Chardan Capital Markets; tgt $21
    • GitLab (GTLB) initiated with a Buy at Needham; tgt $70
    • Global Medical REIT (GMRE) initiated with a Mkt Perform at JMP Securities
    • Harmony Biosciences (HRMY) initiated with a Buy at Mizuho; tgt $64
    • Intra-Cellular Therapies (ITCI) initiated with a Buy at Mizuho; tgt $74
    • JFrog (FROG) initiated with a Buy at Canaccord Genuity; tgt $30
    • New Relic (NEWR) initiated with a Buy at Canaccord Genuity; tgt $81
    • PagerDuty (PD) initiated with a Buy at Canaccord Genuity; tgt $32
    • Rover Group (ROVR) initiated with a Neutral at JP Morgan; tgt $5
    • Splunk (SPLK) initiated with a Buy at Canaccord Genuity; tgt $130
    • UiPath (PATH) assumed with a Buy at Canaccord Genuity; tgt $25